Comment on the work The place of Exemestane in the treatment of metastatic breast cancer in postmenopausal patients

被引：0
|
作者：
Krzakowski, Maciej [1 ]
机构：
[1] Ctr Onkol Inst Im Marii Sklodowskiej Curie, Klin Nowotworow Pluca & Klatki Piersiowej, Warsaw, Poland
来源：
ONCOLOGY IN CLINICAL PRACTICE | 2012年 / 8卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：252 / 254
页数：3
相关论文
共 50 条
  • [41] Exemestane/palbociclibPseudoprogression of metastatic breast cancer: case report
    Reactions Weekly, 2020, 1824 (1) : 132 - 132
  • [42] Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: A Dutch TEAM trial analysis
    van Nes, Johanna G. H.
    Beex, Louk V. A. M.
    Seynaeve, Caroline
    Putter, Hein
    Sramek, Alexandr
    Lardenoije, Susanne
    Duijm-de Carpentier, Marjolijn
    Van Rongen, Inge
    Nortier, Johan W. R.
    Zonderland, Harmien M.
    van de Velde, Cornelis J. H.
    ACTA ONCOLOGICA, 2015, 54 (03) : 349 - 360
  • [43] TREATMENT OF POSTMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER WITH AMINOGLUTETHIMIDE
    STIER, G
    GURTLER, R
    SCHMIDT, UM
    MULLER, U
    TANNEBERGER, S
    ZENTRALBLATT FUR GYNAKOLOGIE, 1990, 112 (17): : 1101 - 1104
  • [44] First line hormonal treatment (HT) for metastatic breast cancer (MBC) with exemestane (E) or tamoxifen (T) in postmenopausal patients (pts) - A randomized phase III trial of the EORTC Breast Group
    Paridaens, R
    Therasse, P
    Dirix, L
    Beex, L
    Piccart, M
    Cameron, D
    Cufer, T
    Roozendaal, K
    Nooij, M
    Mattiacci, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 6S - 6S
  • [45] Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
    Paridaens, Robert J.
    Dirix, Luc Y.
    Beex, Louk V.
    Nooij, Marianne
    Cameron, David A.
    Cufer, Tanja
    Piccart, Martine J.
    Bogaerts, Jan
    Therasse, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4883 - 4890
  • [46] Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer
    Per E. Lønning
    Breast Cancer Research and Treatment, 1998, 49 : S45 - S52
  • [47] Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer
    Lonning, PE
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (Suppl 1) : S45 - S52
  • [48] In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients
    Geisler, J
    King, N
    Anker, G
    Ornati, G
    Di Salle, E
    Lonning, PE
    Dowsett, M
    CLINICAL CANCER RESEARCH, 1998, 4 (09) : 2089 - 2093
  • [49] Efficacy of Exemestane after Nonsteroidal Aromatase Inhibitor Use in Metastatic Breast Cancer Patients
    Kim, Sun Hye
    Park, In Hae
    Lee, Hyewon
    Lee, Keun Seok
    Nam, Byung-Ho
    Ro, Jungsil
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 979 - 983
  • [50] Exemestane - A review of its use in postmenopausal women with advanced breast cancer
    Clemett, D
    Lamb, HM
    DRUGS, 2000, 59 (06) : 1279 - 1296
12345